Axel Mescheder
Vorstandsvorsitzender bei Cristal Delivery BV
Profil
Axel Mescheder is currently the Chief Executive & Medical Officer at Cristal Delivery BV since 2018.
Prior to this, he worked as the Director-Research & Development at MediGene AG, Chief Medical Officer at MorphoSys AG, and Chief Medical & Development Officer at Topotarget A.
He also worked as a Research Physician at the University of Cincinnati (Ohio).
Dr. Mescheder holds a doctorate degree from the University of Kiel.
Aktive Positionen von Axel Mescheder
| Unternehmen | Position | Beginn |
|---|---|---|
Cristal Delivery BV
 Cristal Delivery BV Pharmaceuticals: MajorHealth Technology Cristal Delivery BV develops and manufactures nanomedicines for therapeutic drug optimization. It offers pipeline, oncology, and inflammation programs. The company was founded by Joost J. M. Holthuis and Cristianne Rijcken in April 2011 and is headquartered in Maastricht, the Netherlands. | Vorstandsvorsitzender | 02.11.2018 |
Ehemalige bekannte Positionen von Axel Mescheder
| Unternehmen | Position | Ende |
|---|---|---|
| TOPOTARGET A/S | Technik-/Wissenschafts-/F&E-Leiter | 31.10.2012 |
| MEDIGENE AG | Technik-/Wissenschafts-/F&E-Leiter | 15.09.2008 |
| MORPHOSYS AG | Technik-/Wissenschafts-/F&E-Leiter | - |
| University of Cincinnati (Ohio) | Corporate Officer/Principal | - |
Ausbildung von Axel Mescheder
| University of Kiel | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| MEDIGENE AG | Health Technology |
| MORPHOSYS AG | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Topotarget A/S
 Topotarget A/S Pharmaceuticals: MajorHealth Technology Topotarget A/S is a biotechnology company that is engaged in the development and commercialization of novel drugs for the treatment of cancer. Its product belinostat is a novel histone deacetylase inhibitor which is used for cancer patients. The company was founded by Peter Buhl Jensen and Maxwell Sehested in 2000 and is headquartered in Copenhagen, Denmark. | Health Technology |
Cristal Delivery BV
Cristal Delivery BV Pharmaceuticals: MajorHealth Technology Cristal Delivery BV develops and manufactures nanomedicines for therapeutic drug optimization. It offers pipeline, oncology, and inflammation programs. The company was founded by Joost J. M. Holthuis and Cristianne Rijcken in April 2011 and is headquartered in Maastricht, the Netherlands. | Health Technology |
